Skip to main content
. 2019 Feb 1;21(2-3):e3064. doi: 10.1002/jgm.3064

Figure 3.

Figure 3

Antitumor effect of EHMK‐51‐35 carrier cells in syngeneic mouse model. EHMK51–35 carrier cells infected with AdE3‐midkine and ad‐mGM‐CSF were injected three times into (A) OVHM ovarian cancer subcutaneous tumors and (B) intraperitoneal disseminated tumors after pre‐immunization of adenovirus. Results are shown as a Kaplan–Meier survival curve